Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting

Objective Several studies have analyzed a correlation between the apparent diffusion coefficient (ADC) derived from diffusion-weighted MRI and the tumor cellularity of corresponding histopathological specimens in brain tumors with inconclusive findings. Here, we compared a large dataset of ADC and cellularity values of stereotactic biopsies of glioblastoma patients using a new postprocessing approach including trajectory analysis and automatic nuclei counting. Materials and Methods Thirty-seven patients with newly diagnosed glioblastomas were enrolled in this study. ADC maps were acquired preoperatively at 3T and coregistered to the intraoperative MRI that contained the coordinates of the biopsy trajectory. 561 biopsy specimens were obtained; corresponding cellularity was calculated by semi-automatic nuclei counting and correlated to the respective preoperative ADC values along the stereotactic biopsy trajectory which included areas of T1-contrast-enhancement and necrosis. Results There was a weak to moderate inverse correlation between ADC and cellularity in glioblastomas that varied depending on the approach towards statistical analysis: for mean values per patient, Spearman’s ρ = -0.48 (p = 0.002), for all trajectory values in one joint analysis Spearman’s ρ = -0.32 (p < 0.001). The inverse correlation was additionally verified by a linear mixed model. Conclusions Our data confirms a previously reported inverse correlation between ADC and tumor cellularity. However, the correlation in the current article is weaker than the pooled correlation of comparable previous studies. Hence, besides cell density, other factors, such as necrosis and edema might influence ADC values in glioblastomas.

[1]  S. Cha,et al.  Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System Lymphoma , 2010, American Journal of Neuroradiology.

[2]  Christopher Nimsky,et al.  Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. , 2006, Radiology.

[3]  A. Brodbelt,et al.  Cellularity and apparent diffusion coefficient in oligodendroglial tumours characterized by genotype , 2010, Journal of Neuro-Oncology.

[4]  A. Lagares,et al.  A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas , 2014, American Journal of Neuroradiology.

[5]  P. LaViolette,et al.  Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity , 2010, Journal of magnetic resonance imaging : JMRI.

[6]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[7]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[8]  Mitchel S Berger,et al.  Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. , 2012, Neuro-oncology.

[9]  [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma]. , 2005, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[10]  Aidos Doskaliyev,et al.  Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T. , 2012, European journal of radiology.

[11]  T. Hirai,et al.  Magnetic resonance imaging of pilocytic astrocytomas: usefulness of the minimum apparent diffusion coefficient (adc) value for differentiation from high-grade gliomas , 2008, Acta radiologica.

[12]  R C McKinstry,et al.  Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. , 2001, AJR. American journal of roentgenology.

[13]  James M Provenzale,et al.  Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. , 2002, Radiology.

[14]  Alexander Radbruch,et al.  Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging. , 2014, Radiology.

[15]  Marc Lartaud,et al.  Analyzing huge pathology images with open source software , 2013, Diagnostic Pathology.

[16]  P. LaViolette,et al.  Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma. , 2014, Neuro-oncology.

[17]  Inas S. Khayal,et al.  Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM , 2009, Journal of Neuro-Oncology.

[18]  J.,et al.  The New England Journal of Medicine , 2012 .

[19]  S. Higano,et al.  Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas , 2009, Neurological research.

[20]  Usha Sinha,et al.  Relationships Between Choline Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficient and Quantitative Histopathology in Human Glioma , 2000, Journal of Neuro-Oncology.

[21]  S. Higano,et al.  Minimum apparent diffusion coefficient for the differential diagnosis of ganglioglioma , 2009, Neurological research.

[22]  C. Decaestecker,et al.  Apparent Diffusion Coefficient and Cerebral Blood Volume in Brain Gliomas: Relation to Tumor Cell Density and Tumor Microvessel Density Based on Stereotactic Biopsies , 2008, American Journal of Neuroradiology.

[23]  Ying Lu,et al.  Survival analysis in patients with glioblastoma multiforme: Predictive value of choline‐to‐n‐acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume , 2004, Journal of magnetic resonance imaging : JMRI.

[24]  S. Ng,et al.  Primary Cerebral Lymphoma and Glioblastoma Multiforme: Differences in Diffusion Characteristics Evaluated with Diffusion Tensor Imaging , 2008, American Journal of Neuroradiology.

[25]  Toshinori Hirai,et al.  Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.

[26]  Yutaka Imai,et al.  Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer , 2008, Radiation Medicine.

[27]  T. Hirai,et al.  Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. , 2007, Radiology.

[28]  K. Kono,et al.  The role of diffusion-weighted imaging in patients with brain tumors. , 2001, AJNR. American journal of neuroradiology.

[29]  T. Hirai,et al.  Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. , 2006, AJNR. American journal of neuroradiology.

[30]  P. Loehrer Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma , 2006 .

[31]  Lihua Chen,et al.  The Correlation between Apparent Diffusion Coefficient and Tumor Cellularity in Patients: A Meta-Analysis , 2013, PloS one.

[32]  Walter Stummer,et al.  The importance of surgical resection in malignant glioma , 2009, Current opinion in neurology.

[33]  D. Yousem,et al.  ADC values and prognosis of malignant astrocytomas: does lower ADC predict a worse prognosis independent of grade of tumor?--a meta-analysis. , 2013, AJR. American journal of roentgenology.

[34]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.